Friday, July 10, 2026

pharma · Hypertension · Breast Neoplasms

Pfizer

Pfizer is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Hypertension, Breast Neoplasms, Complicated Intra-abdominal Infection, Non-Small Cell Lung Cancer, Arthritis, Rheumatoid

New York 10017, US HQ
103,316 Employees
EMA registrant Type
Company details
Clinical program

pregabalin and celecoxib

Approved · small molecule · Chronic Low Back Pain With a Neuropathic Component

pregabalin and celecoxib for Chronic Low Back Pain With a Neuropathic Component is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).

← All Pfizer projects Approved small molecule terminated

Internal code A0081296

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pfizer
Phase
Approved
Modality
small_molecule
Indication
Chronic Low Back Pain With a Neuropathic Component
Status
terminated
Trials
1